SEC 13F Intelligence

Global Imc LLC / NBP

Global Imc LLC’s Novabridge Biosciences Position

Does Global Imc LLC own Novabridge Biosciences (NBP)? Not currently — the last reported position was 63.1K shares worth $5M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q2 2021
Shares
63.1K
% of Portfolio
+1.47%
Quarters Held
1
position exited

Position History NBP

Reported value by quarter
Q2 ’21: $5MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202163.1K$5M+1.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of NBP.